AllSquare Wealth Management LLC - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 22 filers reported holding INMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AllSquare Wealth Management LLC ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
5450.0%0.00%
-100.0%
Q1 2022$1,0000.0%5450.0%0.00%0.0%
Q4 2021$1,0000.0%5450.0%0.00%0.0%
Q3 2021$1,000
-50.0%
5450.0%0.00%0.0%
Q2 2021$2,0000.0%5450.0%0.00%0.0%
Q1 2021$2,0000.0%5450.0%0.00%0.0%
Q4 2020$2,0005450.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 235,000$776,0000.02%
Hudson Bay Capital Management LP 161,000$531,0000.01%
AllSquare Wealth Management LLC 545$2,0000.00%
Creative Planning 10,990$36,0000.00%
ROYAL BANK OF CANADA 586$2,0000.00%
TCI Wealth Advisors, Inc. 125$00.00%
UBS Group AG 793$3,0000.00%
OSAIC HOLDINGS, INC. 936$4,0000.00%
BANK OF AMERICA CORP /DE/ 16,120$53,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,820$6,0000.00%
View complete list of INMED PHARMACEUTICALS INC shareholders